Evaluation of paliperidone palmitate long‐acting injectable antipsychotic therapy as an early treatment option in patients with schizophrenia

AIM: This exploratory post hoc analysis of a randomized, double‐blind (DB), multicentre, non‐inferiority study (NCT01515423) evaluated the effects of the long‐acting injectable antipsychotic therapies once‐monthly paliperidone palmitate (PP1M) and once‐every‐3‐months paliperidone palmitate (PP3M) on...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Brianne, Turkoz, Ibrahim, Mancevski, Branislav, Mathews, Maju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384107/
https://www.ncbi.nlm.nih.gov/pubmed/31515972
http://dx.doi.org/10.1111/eip.12868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384107/
https://www.ncbi.nlm.nih.gov/pubmed/31515972
http://dx.doi.org/10.1111/eip.12868

Ejemplares similares